{
    "company_name": "AstraZeneca",
    "file_name": "5bb5f71d1457f3272adab97d64a79c300da75cea",
    "data_points": [
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                9,
                11,
                62
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                156,
                140,
                141,
                160,
                161,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (units/year)",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (liters/year)",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                156,
                174
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (units/year)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (liters/year)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                213,
                214
            ]
        },
        {
            "company_name": "AstraZeneca PLC",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                213,
                214
            ]
        }
    ],
    "events": [
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                8,
                9,
                65
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                10,
                9,
                62
            ]
        },
        {
            "event_type": "has_capital_expenditures",
            "events_src_pdf_page": [
                10,
                11,
                12
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                10,
                11,
                12
            ]
        },
        {
            "event_type": "has_regulatory_or_litigation_issues",
            "events_src_pdf_page": [
                8,
                9,
                10,
                11,
                12
            ]
        },
        {
            "event_type": "has_executive_compensation",
            "events_src_pdf_page": [
                8,
                9,
                12
            ]
        },
        {
            "event_type": "has_financial_performance_indicators",
            "events_src_pdf_page": [
                10,
                9,
                11
            ]
        },
        {
            "event_type": "has_guidance_updates",
            "events_src_pdf_page": [
                8,
                9,
                10,
                11
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                186,
                176,
                118
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                156,
                184,
                187
            ]
        },
        {
            "event_type": "has_capital_expenditures",
            "events_src_pdf_page": [
                159,
                186
            ]
        },
        {
            "event_type": "Mentions recent mergers and acquisitions",
            "events_src_pdf_page": [
                200,
                214
            ]
        },
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                201,
                202
            ]
        },
        {
            "event_type": "has_executive_compensation",
            "events_src_pdf_page": [
                204,
                205
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                206,
                207
            ]
        }
    ]
}